Botulinum toxin in the treatment of myofascial pain syndrome

Pain

Volumn 59, Issue 1, 1994, Pages 65-69

  Cheshire, William P ^a   Abashian, Sandra W ^a   Mann, J Douglas ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Botulinum toxin; Myofascial pain syndrome

Indexed keywords

BOTULINUM TOXIN A;

ACETYLCHOLINE RELEASE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MUSCLE CONTRACTION; MYOFASCIAL PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; BOTULINUM TOXINS; CHRONIC DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MYOFASCIAL PAIN SYNDROMES; PAIN MEASUREMENT; PAIN THRESHOLD; SPASM;

EID: 0028148918     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(94)90048-5     Document Type: Article

References (42)

1. Autonomic innervation of receptors and muscle fibres in cat skeletal muscle
2. Botulinum toxin treatment in spasmodic torticollis
3. Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread
4. Psoriasiform eruption following intramuscular botulinum A toxin
5. Needle electromyographic evaluation of patients with myofascial or fibromyalgic pain
6. Hypotheses of peripheral and central mechanisms underlying occupational muscle pain and injury
7. Myofascial pain syndromes
8. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis
9. Brachial plexopathy after botulinum toxin injections
10. Posttraumatic cervical dystonia
11. Ratio scales of sensory and affective verbal pain descriptors
12. Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptors: manipulation of affect by diazepam
13. Narcotic analgesia: fentanyl reduces the intensity but not the unpleasantness of painful tooth pulp sensations
14. Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis
15. Polyradiculoneuritis following botulinum toxin therapy
16. Myofascial trigger point injection
17. Myofascial trigger points show spontaneous needle EMG activity
18. Botulism
19. Dystonia and tremor induced by peripheral trauma: predisposing factors
20. Botulinum toxin injections for cervical dystonia
21. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm
22. Therapeutic uses of botulinum toxin
23. Muscle tissue oxygen pressure in primary fibromyalgia
24. The dystonias
25. Trigger points and acupuncture points for pain: correlations and implications
26. Peripheral mechanisms of muscle nociception and local muscle pain
27. The contribution of sleep-wake physiology to fibromyalgia
28. Torticollis
29. Reliability of the pressure algometer as a measure of myofascial trigger point sensitivity
30. Brachial plexopathy after botulinum toxin administration for cervical dystonia
31. Botulinum toxin for blepharospasm: single-fiber EMG studies
32. The relationship of peripheral trauma and pain to dystonia
33. The action of botulinum toxin at the neuromuscular junction
34. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis
35. Trauma and pain in spasmodic torticollis
36. Prevalence of myofascial pain in general internal medicine practice
37. Tension myalgia as a diagnosis at the Mayo Clinic and its relationship to fibrositis, fibromyalgia, and myofascial pain syndrome
38. Posttraumatic torticollis
39. Double-blind study of botulinum toxin in spasmodic torticollis
40. The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain sydrome and no disease
41. Quantitative EMG and muscle tension in painful muscles in fibromyalgia